51
|
Yamamoto S, Kido R, Onishi Y, Fukuma S, Kurita N, Akizawa T, Fukagawa M, Kazama JJ, Ichiei N, Fukuhara S, Fusaro M, Noale M, Tripepi G, Piccoli A, Naso A, Giannini S, Miozzo D, Venturelli C, Pica A, Brunori G, Cristofaro R, Gallieni M, Smith J, Geddes C, Padmanabhan N, Lorthioir A, Guerrot D, Edet S, Hanoy M, Bertrand D, Le Roy F, Godin M. Heart and bone in CKD - B. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
52
|
Lucian Borz B, Durand E, Hauville C, Tron C, Godin M, Canville A, Bauer F, Litzler P, Bessou J, Cribier A, Eltchaninoff H. BASELINE NT–PROBNP AND THE IMPACT OF AORTIC REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT. J Am Coll Cardiol 2013. [DOI: 10.1016/s0735-1097(13)61953-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
53
|
Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Dacher JN, Bauer F, Cribier A, Eltchaninoff H. 136: Performance Analysis of EUROSCORE 2 as Compared to Logistic EuroSCORE and STS Scores for Predicting 30-day Mortality after Transcatheter Aortic Valve Replacement- A Rouen Study. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2013. [DOI: 10.1016/s1878-6480(13)71066-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
54
|
Borz B, Durand E, Godin M, Tron C, Canville A, Litzler PY, Bessou JP, Cribier A, Eltchaninoff H. 134: Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2013. [DOI: 10.1016/s1878-6480(13)71064-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
55
|
Lorthioir A, Joannidès R, Rémy-Jouet I, Fréguin-Bouilland C, Iacob M, Monteil C, Lucas D, Audrezet M, Guerrot D, Richard V, Thuillez C, Godin M, Bellien J. P4.05 POLYCYSTIN DEFICIENCY RESULTS IN COMPLETE LOSS OF NO SYNTHESIS DURING SUSTAINED FLOW-MEDIATED DILATATION OF CONDUIT ARTERIES IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: POSSIBLE REVERSAL BY DOPAMINE. Artery Res 2013. [DOI: 10.1016/j.artres.2013.10.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
56
|
Kurtz B, Godin M, Tron C, Baala B, Cribier A, Helene E, Bauer F. 135: Four-year durability of aortic valve bioprosthesis after transcatheter implantation: an echocardiographic prospective study. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2013. [DOI: 10.1016/s1878-6480(13)71065-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
57
|
Farhat A, Godin M, Abriou C, Borz B, Tron C, Baala B, Tamion F, Eltchaninoff H. 313: Prognostic factors in out of hospital cardiac arrest: a new score (DAANS) to guide the optimal management? ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2013. [DOI: 10.1016/s1878-6480(13)71244-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
58
|
Borz B, Durand E, Godin M, Tron C, Canville A, Litzler PY, Bessou JP, Cribier A, Eltchaninoff H. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 2012; 99:860-5. [DOI: 10.1136/heartjnl-2012-303095] [Citation(s) in RCA: 80] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
|
59
|
Borz B, Durand E, Godin M, Tron C, Litzler PY, Bessou JP, Canville A, Cribier A, Eltchaninoff H. TCT-868 Incidence, Predictors and Impact of Bleeding after Transcatheter Aortic Valve Implantation. J Am Coll Cardiol 2012. [DOI: 10.1016/j.jacc.2012.08.914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
60
|
Hanoy M, Le Roy F, Loron MC, Godin M. Intérêt du rétrocontrôle de la volémie plasmatique dans la prévention des épisodes hypotensifs intradialytiques. Nephrol Ther 2012. [DOI: 10.1016/j.nephro.2012.07.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
61
|
Bouhzam N, Nkhali L, Borz B, Godin M, Cribier A, Eltchaninoff H. Heart failure as herald. Am J Med 2012; 125:880-1. [PMID: 22800872 DOI: 10.1016/j.amjmed.2012.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2012] [Revised: 04/30/2012] [Accepted: 05/01/2012] [Indexed: 11/16/2022]
|
62
|
Levasseur C, Drouineau O, Roca F, Bessin C, Menard JF, Ryckelynck JP, Godin M, Chassagne P. Insuffisance rénale chronique terminale du sujet âgé. Impact des caractéristiques fonctionnelles gériatriques sur l’initiation d’une épuration extrarénale. Nephrol Ther 2012. [DOI: 10.1016/j.nephro.2012.07.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
63
|
Tron C, Godin M, Litzler PY, Bauer F, Caudron J, Dacher JN, Borz B, Canville A, Kurtz B, Bessou JP, Cribier A, Eltchaninoff H. [Selection of patients for transcatheter aortic valve implantation]. Presse Med 2012; 41:628-33. [PMID: 22538202 DOI: 10.1016/j.lpm.2012.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2012] [Revised: 03/15/2012] [Accepted: 03/16/2012] [Indexed: 10/28/2022] Open
Abstract
A good selection of patients is a crucial step before transcatheter aortic valve implantation (TAVI) in order to select the good indications and choose the access route. TAVI should be considered only in patients with symptomatic severe aortic stenosis and either contraindication or high surgical risk. Indication for TAVI should be discussed in a multidisciplinary team meeting. Echocardiography and/or CT scan are mandatory to evaluate the aortic annulus size and select the good prosthesis size. The possibility of transfemoral implantation is evaluated by angiography and CT scan, and based on the arterial diameters, but also on the presence of tortuosities and arterial calcifications.
Collapse
|
64
|
Moubarak G, Ernande L, Godin M, Cazeau S, Vicaut E, Hanon O, Zuily S, Tournoux F, Danchin N, Derumeaux G, Mechulan A. Impact of comorbidity on medication use in elderly patients with cardiovascular diseases: the OCTOCARDIO study. Eur J Prev Cardiol 2012; 20:524-30. [PMID: 22447578 DOI: 10.1177/2047487312444235] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Recommended medications are under-prescribed in elderly patients with atrial fibrillation (AF), coronary artery disease (CAD), and congestive heart failure (CHF). The relationship between under-prescribing and comorbidity is unclear. DESIGN Single-day observational study. METHODS Analysis of medications taken by patients aged 80 years or over at the time of their admission to cardiology units of 32 French hospitals. Comorbidity was measured using the Charlson comorbidity index (CCI). RESULTS The study included 510 patients (57% men, mean age 85 years). History of AF, CHF, and CAD was present in 213 (42%), 199 (39%), and 187 (37%) patients, respectively. CCI was 0 in 110 (22%), 1-2 in 215 (42%), and ≥3 in 185 (36%) patients. Vitamin K antagonists (VKA) were prescribed to 105 (49%) and aspirin to 86 (40%) patients with AF. CCI did not influence VKA prescription but influenced aspirin use, with lower prescription rates in patients with CCI 1-2 than CCI 0 or CCI ≥3 (p = 0.02). In CHF, angiotensin-converting enzyme inhibitors (ACEI) and β-blockers were prescribed to 80 (40%) and 96 (48%) patients, respectively. Rates of prescription of ACEI, β-blockers, statins, and aspirin in patients with CAD were 43%, 56%, 56%, and 66%, respectively. CCI level did not influence any medication use in CHF and CAD. CONCLUSION Even in the absence of comorbidity, elderly patients with major cardiovascular diseases are denied from indicated medical treatments probably because of their age alone. Implementing measures to enhance awareness of treatment benefits and promote appropriate prescribing is necessary.
Collapse
|
65
|
Litzler PY, Borz B, Smail H, Baste JM, Nafeh-Bizet C, Gay A, Tron C, Godin M, Caudron J, Hauville C, Dacher JN, Cribier A, Eltchaninoff H, Bessou JP. Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesis. Arch Cardiovasc Dis 2012; 105:141-5. [PMID: 22520796 DOI: 10.1016/j.acvd.2012.02.005] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2012] [Accepted: 02/03/2012] [Indexed: 11/17/2022]
Abstract
BACKGROUND The first French transapical transcatheter aortic valve implantation (TAVI) was performed in July 2007 in our department. AIMS To report 4-year outcomes of transapical implantation with the Edwards transcatheter bioprosthesis. METHODS We prospectively evaluated consecutive patients who underwent transapical implantation with an Edwards transcatheter bioprosthesis between July 2007 and October 2011. Patients were not suitable for conventional surgery (due to severe comorbidities) or transfemoral implantation (due to poor femoral access). RESULTS Among 61 patients (59.0% men), mean logistic EuroSCORE was 27.5 ± 14.9% and mean age was 81.0 ± 6.8 years. Successful valve implantation was achieved in 59/61 patients (96.7%) of patients. The other two patients required conversion to conventional surgery due to prosthesis embolization and died. Six additional patients died in the postoperative period. Causes of perioperative death were two septic shocks (one of peritonitis), two multi-organ failure, one ventricular fibrillation and one respiratory insufficiency. Intraprocedural stroke was not observed in any patient. The actuarial survival rates at 1, 2 and 4 years were 73.8%, 67.2% and 41.0%. During this 4-year period, four patients died of cardiovascular events, but no impairment of transprosthesis gradient was observed. CONCLUSION Our series of 61 patients who underwent transapical implantation of the Edwards transcatheter bioprosthesis shows satisfactory results, similar to other reports, considering the high level of severity of patients referred for this method. Transapical access is a reliable alternative method for patients that cannot benefit from a transfemoral approach.
Collapse
|
66
|
Eltchaninoff H, Durand É, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses. Arch Cardiovasc Dis 2012; 105:132-40. [DOI: 10.1016/j.acvd.2012.02.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2012] [Revised: 02/01/2012] [Accepted: 02/01/2012] [Indexed: 10/28/2022]
|
67
|
Godin M, Borz B, Tron C, Durand E, Doguet F, Bessou JP, Litzler PY, Cribier A, Eltchaninoff H. 201 Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with contra-indication to surgery but low (<20%) logistic Euroscore: results of the Rouen registry. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2012. [DOI: 10.1016/s1878-6480(12)70597-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
68
|
Joannidès R, Monteil C, de Ligny BH, Westeel PF, Iacob M, Thervet E, Barbier S, Bellien J, Lebranchu Y, Seguin SG, Thuillez C, Godin M, Etienne I. Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant 2011; 11:2414-22. [PMID: 21929645 DOI: 10.1111/j.1600-6143.2011.03697.x] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Whether or not a cyclosporine A (CsA)-free immunosuppressant regimen based on sirolimus (SRL) prevents aortic stiffening and improves central hemodynamics in renal recipients remains unknown. Forty-four patients (48 ± 2 years) enrolled in the CONCEPT trial were randomized at week 12 (W12) to continue CsA or switch to SRL, both associated with mycophenolate mofetil. Carotid systolic blood pressure (cSBP), pulse pressure (cPP), central pressure wave reflection (augmentation index, AIx) and carotid-to-femoral pulse-wave velocity (PWV: aortic stiffness) were blindly assessed at W12, W26 and W52 together with plasma endothelin-1 (ET-1), thiobarbituric acid-reactive substances (TBARS) and superoxide dismutase (SOD) and catalase erythrocyte activities. At W12, there was no difference between groups. At follow-up, PWV, cSBP, cPP and AIx were lower in the SRL group. The difference in PWV remained significant after adjustment for blood pressure and eGFR. In parallel, ET-1 decreased in the SRL group, while TBARS, SOD and catalase erythrocyte activities increased in both groups but to a lesser extent in the SRL group. Our results demonstrate that a CsA-free regimen based on SRL reduces aortic stiffness, plasma endothelin-1 and oxidative stress in renal recipients suggesting a protective effect on the arterial wall that may be translated into cardiovascular risk reduction.
Collapse
|
69
|
Hanoy M, Le Roy F, Grange S, Renou M, Bertrand D, Gavard M, Godin M. Courbes de volémie plasmatique en hémodialyse et hémodynamique per-dialytique. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
70
|
Grangé S, Hanoy M, Renou M, Gavard MS, Le Roy F, Godin M. Caractérisation des paramètres hémodynamiques per-dialytiques associés au phénomène d’hypertension artérielle intra-dialytique. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
71
|
Gavard M, Le Roy F, Hanoy M, Freguin C, Godin M. Évaluation de l’hypertension artérielle chez des patients hémodialysés chroniques. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
72
|
Grangé S, Legallicier B, Francois A, Soulis F, Guerrot D, Freguin-Bouilland C, Godin M. Étude de corrélation entre index de résistance vasculaire et indices histomorphométriques rénaux chez le patient transplanté rénal. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
73
|
Godron A, Harambat J, Mensire A, May A, Merville P, Godin M, Chauveau D, Cochat P, Bouissou F, Guest G, Blanchard A, Vargas-Poussou R. Syndrome d’hypomagnésémie, hypercalciurie, néphrocalcinose familiale (FHHNC) : histoire naturelle et corrélation phénotype génotype chez 29 patients porteurs de mutations des gènes CLDN16 ou CLDN19. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
74
|
Freguin C, Étienne I, Benard L, Hanoy M, Le Roy F, Gavard MS, Legallicier B, Godin M. Il est plus facile d’améliorer les facteurs de risque cardiovasculaire des transplantés rénaux qui relèvent d’un traitement médicamenteux que ceux qui relèvent de mesures diététiques. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
75
|
Laurent C, Grangé S, Hanoy M, Le Roy F, Godin M. À propos d’un cas de calcinose tumorale traité par hémodiafiltration post-dilution quotidienne. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
76
|
Grangé S, Legallicier B, Francois A, Soulis F, Guerrot D, Freguin-Bouilland C, Godin M. Étude de corrélation entre index de résistance vasculaire et indices histomorphométriques rénaux. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
77
|
Couzi L, Moulin B, Morin M, Albano L, Godin M, Barrou B, Alamartine E, Morelon E, Girardot-Seguin S, Misdrahi D, Cassuto E, Merville P. Facteurs prédictifs de l’observance en transplantation rénale : étude observationnelle française. Nephrol Ther 2011. [DOI: 10.1016/j.nephro.2011.07.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
78
|
Doguet F, Hauville C, Godin M. A biatrial myxoma revealed by pulmonary embolism. Arch Cardiovasc Dis 2011; 104:421-2. [DOI: 10.1016/j.acvd.2010.08.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2010] [Revised: 08/10/2010] [Accepted: 08/24/2010] [Indexed: 10/18/2022]
|
79
|
Belizna C, Loufrani L, Subra JF, Godin M, Jolly P, Vitecocq O, Faller B, Ghali A, Tron F, Hamidou M, Henrion D, Lévesque H, Ifrah N. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmun Rev 2011; 10:559-62. [PMID: 21549859 DOI: 10.1016/j.autrev.2011.04.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2011] [Accepted: 04/14/2011] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Cryofibrinogenemia may be essential, or secondary to diseases such as neoplasia, infection, thrombosis, and collagen vascular diseases. In a previous study, we reported the occurrence of neoplasia in some essential cryofibrinogenemia patients after a short period of follow-up. PURPOSE We performed a prospective multi-center 5-year follow-up study in essential cryofibrinogenemia patients (2005-2009). RESULTS 23 patients with essential cryofibrinogenemia were included, mean age 59 years (range: 33-79), 14 males. After a mean follow-up period of 24 months, 11/23 (47%) of cases that were initially diagnosed as essential cryofibrinogenemia were found to have an underlying lymphoma (6 T lymphoma and 5 B lymphoma). CONCLUSION This prospective study suggests that some cases of cryofibrinogenemia that are initially considered as essential, may have underlying lymphoma. Thus, we further suggest that regular follow-up should be performed in patients with essential cryofibrinogenemia.
Collapse
|
80
|
Fares J, Eltchaninoff H, Godin M, Tron C, Bauer F, Baala B, Cribier A. CATASTROPHIC OUTCOME OF UNTREATED PATIENTS WITH SEVERE SYMPTOMATIC AORTIC STENOSIS. J Am Coll Cardiol 2011. [DOI: 10.1016/s0735-1097(11)61370-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
81
|
Forchuk C, Giustizia S, Annett N, Connoy M, Csiernik R, Diaz K, Edwards B, Elkin D, Fisman S, Godin M, Jeng M, Laverty K, Mitchell B, Norman R, Ouseley S, Richardson J, Rudnick A, Wilk P. FC27-01 - Youth matters in London: Mental health, addiction and homelessness. Eur Psychiatry 2011. [DOI: 10.1016/s0924-9338(11)73668-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
This project will work closely with existing service partners involved in street level services and focus on testing and evaluating three approaches for street level interventions for youth who are homeless and who have severe or moderate mentally illness. Youth will be asked to choose their preferred service approach:Housing First related initiatives focused on interventions designed to move youth to appropriate and available housing and ongoing housing supports.Treatment First initiatives to provide Mental Health/Addiction supports and treatment solutions, and; Simultaneous attention to both Housing and Treatment TogetherOur primary objective is to understand the service delivery preferences of homeless youth and understand the outcomes of these choices. Our research questions include:1.Which approaches to service are chosen by youth?2.What are the differences and similarities between groups choosing each approach?3.What are the critical ingredients needed to effectively implement services for homeless youth from the perspectives of youth, families and service providers?Focus groups with staff and family members will occur to assist in understanding the nature of each of service approach, changes that evolve within services, & facilitators and barriers to service delivery. This work will be important in determining which approach is chosen by youth and why. Evaluating the outcomes with each choice will provide valuable information about outcomes for the service options chosen by youth. This assist in better identifying weaknesses in the services offered and inform further development of treatment options that youth will accept.
Collapse
|
82
|
Hamdan-Challe M, Godin M, Bouchart F, Doguet F. Isolated ventricular septal rupture secondary to blunt trauma. Interact Cardiovasc Thorac Surg 2010; 11:667-9. [DOI: 10.1510/icvts.2010.242602] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
83
|
|
84
|
Godin M, Eltchaninoff H, Furuta A, Tron C, Anselme F, Bejar K, Sanchez-Giron C, Bauer F, Litzler PY, Bessou JP, Cribier A. Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol 2010; 106:707-12. [PMID: 20723650 DOI: 10.1016/j.amjcard.2010.04.029] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2010] [Revised: 04/15/2010] [Accepted: 04/15/2010] [Indexed: 11/30/2022]
Abstract
We evaluated the incidence of conduction abnormalities and requirement for permanent pacemaker in patients undergoing transcatheter aortic valve implantation (TAVI) with the Edwards Sapien prosthesis. In 2009, >8,000 patients were treated with TAVI using 1 of the 2 commercialized models of bioprosthesis (Edwards Sapien, Edwards Lifesciences, Irvine, California; and CoreValve, Medtronic, Irvine, California). Occurrence of conduction abnormalities including complete atrioventricular block requiring permanent pacemaker has been reported after TAVI with the 2 models of valve, more frequently with the CoreValve. We analyzed standard 12-lead electrocardiograms of 69 consecutive patients in whom an Edwards Sapien prosthesis was successfully implanted. Electrocardiograms were examined before treatment, at day 1, and at 1-month follow-up. Heart rate, PR and QT intervals and QRS duration were measured and the presence of a first-, second-, or third-degree atrioventricular block was documented. There was a slight increase in heart rate and a discrete decrease in QT interval at day 1. These values had returned to baseline values at 1 month. There was no change in PR interval but a transitory increase in QRS duration was noted. Frequency of left bundle branch block increased from 14.5% at baseline to 27.5% at day 1 with a decreased incidence at day 30 (21.3%). Permanent pacemaker was required in only 3 patients (4.3%). In conclusion, in our experience, conductive disorders and requirement of a definitive pacemaker after implantation of an Edwards Sapien aortic bioprosthesis are infrequent. The physical properties of this prosthesis may explain this observation.
Collapse
|
85
|
Belizna C, Godin M, Joly P, Vittecoq O, Hamidou M, Faller B, Lévesque H. Étude prospective à cinq ans de 21 cas de cryofibrinogénémie essentielle. Rev Med Interne 2010. [DOI: 10.1016/j.revmed.2010.03.428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
86
|
Furuta A, Bejar K, Eltchaninoff H, Tron C, Baala B, Godin M, Giron CS, Borz B, Cribier A. ROLE OF PERCUTANEOUS BALLOON AORTIC VALVULOPLASTY FOR CALCIFIC AORTIC STENOSIS: UPDATED TECHNIQUE, INDICATIONS AND IMMEDIATE HAEMODYNAMIC RESULTS IN A HIGHLY EXPERIENCED CENTER. J Am Coll Cardiol 2010. [DOI: 10.1016/s0735-1097(10)61411-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
87
|
Godin M, Furuta A, Eltchaninoff H, Tron C, Bejar K, Bordz B, Baala B, Cribier A. 171 Definitive pacemaker requirement after percutaneous Edwards Sapien aortic valve implantation: a rare complication. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2010. [DOI: 10.1016/s1878-6480(10)70173-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
88
|
Bejar K, Tron C, Eltchaninoff H, Litzler PY, Godin M, Cauliez B, Sanchez-Giron C, Cribier A. 177 Does transcutaneous aortic valve implantation induce myocardial injury? ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2010. [DOI: 10.1016/s1878-6480(10)70179-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
89
|
Sanchez-Giron C, De Icaza M, Eltchaninoff H, Godin M, Tron C, Baala B, Cribier A. 158 Circularity Index of deployed Edwards Sapien aortic valve bioprosthesis. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS 2010. [DOI: 10.1016/s1878-6480(10)70160-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
90
|
Claeyssens S, LeRoy F, Brunel V, Quillard M, Godin M, Lavoinne A. 1339 Free light chains in patients with renal impairment associated or not with hypergammaglobulinemia. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70512-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
91
|
Eltchaninoff H, Kerkeni M, Zajarias A, Tron C, Godin M, Sanchez Giron C, Baala B, Cribier A. Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis. EUROINTERVENTION 2009; 5:438-42. [DOI: 10.4244/eijv5i4a69] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
92
|
Claeyssens S, LeRoy F, Brunel V, Quillard M, Godin M, Lavoinne A. 1337 Free light chains renal handling in patients with plasma cell dyscrasias. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)70510-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
93
|
Cribier A, Litzler PY, Eltchaninoff H, Godin M, Tron C, Bauer F, Bessou JP. Technique of Transcatheter Aortic Valve Implantation with the Edwards-Sapien® Heart Valve Using the Transfemoral Approach. Herz 2009; 34:347-56. [DOI: 10.1007/s00059-009-3264-z] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
94
|
Belizna C, Hamidou M, Faller B, Blaison G, Lavigne C, Godin M, Marie I, Thuillez C, Levesque H. Cryofibrinogénémie et insuffisance rénale. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.03.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
95
|
Freguin C, Joannides R, Roux N, Richard V, Plissonnier D, Thuillez C, Godin M. C018 Mycophenolate mofetil prevents cyclosporine induced endothelial dysfunction in rat allograft aortic model. Arch Cardiovasc Dis 2009. [DOI: 10.1016/s1875-2136(09)72205-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
96
|
Bellien J, Freguin C, Iacob M, Kandil L, Thuillez C, Godin M, Joannides R. P3.07 INCREASED ARTERIAL STIFFNESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. Artery Res 2009. [DOI: 10.1016/j.artres.2009.10.036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
97
|
Godin M, Tron C, Eltchaninoff H, Baala B, Cribier A. [Percutaneous treatment of aortic stenosis]. Ann Cardiol Angeiol (Paris) 2008; 57:321-326. [PMID: 18976740 DOI: 10.1016/j.ancard.2008.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2008] [Accepted: 10/02/2008] [Indexed: 05/27/2023]
Abstract
Degenerative aortic stenosis is the most frequent valvular disease in developed countries. The reference treatment is surgical valve replacement but one third of the patients are not eligible for surgery. Alternative options have been recently proposed using transcatheter valve implantation (transfemoral or trans-apical approaches) in this subset of patients. Two models of valve (balloon expandable or self-expandable) have demonstrated their efficacy and have been implanted to date in over 4000 patients worldwide. These techniques are promising but several issues remain such as the selection of patients, and the safety and durability of the devices currently used.
Collapse
|
98
|
d'Ythurbide G, Coppo P, Adem A, Callard P, Dantal J, Chantrel F, Godin M, Braun-Parvez L, Moulin B, Moskovtchenko P, Ouali N, Rondeau E, Hertig A. Chronic lymphocytic leukemia: a hazardous condition before kidney transplantation. Am J Transplant 2008; 8:2471-5. [PMID: 18782293 DOI: 10.1111/j.1600-6143.2008.02383.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Long-term survival of patients with chronic lymphocytic leukemia (CLL) is over 10 years, and such patients are thus potential kidney recipients in the case of superimposed end-stage renal disease. However, the renal and patient outcome in this condition is unknown. We report the charts of four patients with CLL who were engrafted in France with a deceased-donor kidney and underwent routine triple immunosuppressive therapy. The results show that these patients developed severe infectious episodes (fatal in one case) and tumoral complications including rapid progression of CLL in two cases. Moreover, the graft may be infiltrated and damaged by monoclonal B cells: one patient lost his graft 14 months after transplantation. Various therapeutic options (modifications of the immunosuppressive regimen, anti-CD20 antibodies, irradiation of the graft) showed little (if any) efficacy. Therefore, we believe that CLL is a too hazardous condition to envisage solid organ transplantation with a routine immunosuppressive regimen, and we propose a more appropriate approach.
Collapse
|
99
|
Baguelin-Pinaud A, Moinier D, Fouldrin G, Le Roy F, Etienne I, Godin M, Thibaut F. [Renal transplantation, anxiety and depressive disorders and quality of life]. Encephale 2008; 35:429-35. [PMID: 19853715 DOI: 10.1016/j.encep.2008.06.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2007] [Accepted: 06/06/2008] [Indexed: 10/21/2022]
Abstract
Until now there are few data in the literature describing psychiatric comorbidity in patients waiting for renal transplantation. We have conducted a cross sectional study estimating the prevalence of anxiety and depressive disorders in three groups of renal transplant patients, before transplantation, six months and one year after. The MINI was used to estimate the prevalence of anxiety and depressive disorders. Anxiety and depressive symptoms were assessed using the HAD. Patients' quality of life was also assessed using the SF-36. This study did not find any major impact of renal transplantation on the prevalence of structured psychiatric disorders. Indeed, the prevalence of depressive and anxiety disorders did not differ significantly between the three groups. The mean scores of anxiety did not differ significantly between the three groups in contrast to the mean scores of depression, which differed significantly between the group "before transplantation" and the group "one year after transplantation". We did not find any significant difference concerning the scores of patient's quality of life between the three groups, except for the item "health perceived by the patients themselves". Health perceived by the patients was greater in the group "after transplantation". The quality of life of dialysed or transplant patients was strongly correlated with anxiety and depressive symptoms scores, emphasizing the major interest of a multidisciplinary approach for these patients.
Collapse
|
100
|
Laville M, Legrand A, Godin M, Canaud B, Cristol JP. [Creatinine and prevention of chronic renal insufficiency: an editorial]. Ann Biol Clin (Paris) 2008; 66:261-262. [PMID: 18558563 DOI: 10.1684/abc.2008.0225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|